Genetic Testing for Menopause: What Your DNA Can and Cannot Tell You

You are eating well, lifting weights, protecting your sleep, and doing many of the things that once kept you feeling strong. Yet your body seems to be following a new set of rules. Your energy has changed. Your recovery is slower. Your moods feel less predictable. Your weight or cholesterol may be responding differently than it did a few years ago.

When standard answers feel incomplete, a personalized DNA report can be appealing. Maybe your genes can explain why perimenopause feels so disruptive. Maybe they can reveal the right diet, the best supplements, the ideal exercise plan, or the safest approach to hormone therapy.

Genetic testing can sometimes provide valuable information. It can identify certain inherited health risks, support selected medication decisions, and generate useful questions for a healthcare visit. It can also create false reassurance, unnecessary fear, or highly specific lifestyle recommendations that extend far beyond the available evidence.

In a Menopause Mastery conversation with Tracey Steady-Hardcastle, Dr. Betty Murray explored functional genomics, polygenic scoring, MTHFR, estrogen metabolism, mood, nutrition, exercise, and personalized menopause care. The most useful principle from that discussion is also the most important place to begin:

Your genes can influence susceptibility, but they do not write your entire health story.

This guide explains what genetic testing for menopause can realistically tell you, what it cannot yet prove, and how to use DNA information without letting a commercial report make medical decisions for you.

Medical note: This article is educational and is not a diagnosis or personalized treatment plan. Do not change medication, hormone therapy, cancer screening, supplements, or diet solely because of a consumer genetic report. Clinically important findings should be reviewed and, when appropriate, confirmed by a qualified healthcare professional or genetic counselor.

Why Women Turn to DNA Testing During Perimenopause

Perimenopause often arrives during an already demanding stage of life. Sleep may become less reliable, menstrual cycles may change, body composition can shift, and symptoms may affect mood, concentration, sexual health, and daily performance. When a woman is told that everything looks normal despite feeling different, the promise of a detailed biological blueprint can feel empowering.

Consumer genetic testing also offers something traditional care does not always provide: time to explore. A report may contain dozens of pathways related to metabolism, cardiovascular health, nutrients, exercise, stress, hormones, or medication response.

The challenge is that more data does not automatically mean more certainty. The National Human Genome Research Institute notes that some consumer tests report traits or recommendations without confirmed clinical utility, including suggestions about which vitamins a person should take. Lifestyle traits such as nutrition, fitness, weight, sleep, and food response are complex, and the usefulness of genetic recommendations in these areas is often unclear.1

The right goal is not to dismiss genetics. It is to place each result in the correct evidence category.

Genetic Testing Is Not One Single Thing

The term genetic testing covers several very different tools. A clinical test ordered because of a strong family history is not equivalent to an ancestry kit. An FDA-authorized health-risk report is not equivalent to a third-party interpretation of downloaded raw data. A medication-response result supported by a professional guideline is not equivalent to a wellness report that recommends supplements from a group of common variants.

Type of Test	Primary Purpose	Best Use	Important Limitation
Clinical diagnostic or risk testing	Investigates a defined medical question, such as hereditary breast and ovarian cancer or familial hypercholesterolemia	When personal or family history suggests a specific inherited condition	Results require appropriate test selection and expert interpretation
Direct-to-consumer health-risk testing	Reports selected variants associated with certain conditions or carrier states	Education and discussion with a qualified professional	Often tests only a subset of relevant variants and does not determine overall risk2
Provider-mediated testing	A consumer initiates testing, but a clinician connected to the company approves or orders it	May add some professional involvement	The level of counseling and clinical context varies widely1
Pharmacogenomic testing	Evaluates selected gene and medication relationships	Certain drug decisions supported by validated guidance	Not every gene-drug claim has enough evidence to guide prescribing
Polygenic risk scoring	Combines many common variants into a statistical estimate of relative risk	Emerging risk stratification for selected conditions	Accuracy depends on the model, reference population, ancestry, validation, and clinical context4
Wellness or functional genomics reporting	Connects common variants to diet, supplements, exercise, stress, detoxification, or hormones	May generate questions or motivate healthy behavior	Many specific recommendations have uncertain clinical validity or utility1 3

Before buying a test, identify which category it belongs to. The category often tells you more about how cautiously to interpret the report than the number of genes on the sales page.

Single Gene Variant Versus Polygenic Risk Score

A genetic variant is a difference in DNA sequence. Many variants are common and are part of normal human diversity. The word “mutation” is often used casually in wellness marketing, but it can create the impression that every uncommon result is harmful. In medical genetics, pathogenic variant is a more precise term for a change with established disease relevance.

A single nucleotide polymorphism, or SNP, is a common difference at one DNA position. A SNP can be scientifically interesting without being clinically useful. Its effect may be small, depend on ancestry, or change when combined with other genes, health conditions, behaviors, and environmental exposures.

This is one reason single-gene wellness advice can be misleading. Human traits such as body weight, mood, exercise response, cardiovascular risk, and age at menopause are usually influenced by many factors.

A polygenic risk score attempts to address part of that complexity by combining many variants associated with a condition. The variants are usually weighted according to findings from large genomic studies. The result estimates how a person’s genetic susceptibility compares with people in a reference population.4

That does not make the score a diagnosis.

What a Polygenic Risk Score Can and Cannot Show

The National Human Genome Research Institute explains that a polygenic risk score generally describes relative risk. It does not automatically provide a person’s absolute chance of developing a condition, when it might occur, or whether it will occur at all. These scores show statistical associations, not proof that the variants caused the outcome.4

A Polygenic Score May Help With	A Polygenic Score Does Not Automatically Provide
Estimating whether inherited susceptibility is higher or lower than that of a reference group	A diagnosis
Supporting a discussion about whether further clinical assessment is reasonable	A guaranteed health outcome
Adding genetic information to a validated clinical risk model	A precise timeline
Identifying people who may benefit from further research or carefully designed prevention programs	A supplement prescription
Generating a hypothesis to examine with health history and clinical data	An individualized hormone dose, diet, or exercise program

The construction of the score matters. A clinically credible polygenic score should disclose the condition it predicts, the population used to build it, how the variants were selected and weighted, how the model was validated, and whether adding the score to standard care improves outcomes.

A report that simply groups multiple SNPs into a pathway is not automatically a validated polygenic risk score.

Ancestry also matters. Genomic discovery studies have historically included a disproportionate number of people of European ancestry. A score developed in one population may perform less accurately in another, which can worsen health disparities if this limitation is ignored.4

Genes Are Tendencies, Not Destiny

The podcast uses a helpful recipe metaphor. A single ingredient rarely determines the final dish. Genes interact with other genes, but they also operate within a body shaped by age, hormones, nutrition, movement, sleep, illness, stress, medications, and environmental exposure.

That means a genetic result can be neither a life sentence nor a permission slip.

A higher genetic susceptibility to a condition may justify a closer look, but it does not prove disease. A lower-risk result does not erase family history, symptoms, or the need for routine screening. The FDA emphasizes that consumer health-risk reports do not determine a person’s overall risk and that both genetic and nongenetic factors contribute to disease.2

The most useful question is often not, “What does this gene make me do?” It is, “Does this result identify a credible risk that should be confirmed, monitored, or discussed with a specialist?”

The MTHFR Gene: What Women Need to Know

Few genes have attracted as much wellness attention as MTHFR. This gene helps the body process folate, a B vitamin involved in DNA production and other essential functions.

The two common variants most often discussed are C677T and A1298C. These are common genetic differences, not rare diagnoses. The Centers for Disease Control and Prevention states that more people in the United States have one or two copies of C677T than have neither copy.5

The CDC also directly addresses a common internet claim: people with common MTHFR variants can process all forms of folate, including folic acid. Folic acid intake has a greater influence on blood folate than MTHFR genotype, and a common variant is not a reason to avoid folic acid.5

This matters because a consumer result is sometimes followed by very high-dose methylfolate or multiple methylated supplements. More is not automatically better. A variant alone does not establish a deficiency, prove that a person is “under-methylating,” or determine an ideal supplement dose.

A safer sequence is to examine the clinical question first. Is there a documented folate or vitamin B12 issue? Is homocysteine elevated? Is the person pregnant or planning pregnancy? Are medications, diet, kidney function, or other conditions relevant? The answer should guide testing and supplementation, not a single SNP in isolation.

COMT, Mood, and the “Warrior or Worrier” Problem

COMT is an enzyme involved in the metabolism of catechol compounds. Certain variants can affect enzyme activity, which has made COMT a popular feature in reports about dopamine, stress, estrogen metabolism, pain sensitivity, and personality.

The biology is more complicated than the labels.

Terms such as “slow COMT,” “fast COMT,” “executive gene,” “warrior,” or “worrier” may feel personally accurate, but they are not clinical diagnoses. A single COMT result cannot establish how quickly an individual clears stress chemicals in daily life, explain a personality, predict relationship conflict, or determine whether quercetin, tyrosine, caffeine, or another supplement will improve mood.

Perimenopausal mood changes deserve a broader assessment. Hormone fluctuations, sleep disruption, vasomotor symptoms, life stress, medication effects, thyroid disease, anxiety, depression, alcohol, and other factors can overlap. A genetic hypothesis may be interesting, but it should not replace a mental health or medical evaluation when symptoms are persistent or severe.

The same principle applies to supplement timing. A pathway diagram can show plausible biochemical interactions without proving that a supplement will meaningfully change mood in a specific person.

Can DNA Testing Explain Estrogen Metabolism?

Genetic variation can influence enzymes involved in hormone synthesis, transport, signaling, and metabolism. Research into these pathways may eventually improve precision care. What is not established is the claim that a wellness SNP panel can calculate “estrogen toxicity,” identify a blocked detoxification pathway, or prescribe the exact supplement needed to make hormone therapy work.

The phrase estrogen detoxification can also be misleading. The liver and other tissues metabolize hormones through multiple pathways, and the body excretes metabolites through urine and stool. A variant in one enzyme does not mean the process has stopped.

Genes such as CYP19A1, COMT, and others may be included in commercial hormone reports. Their presence in a biological pathway does not prove that using DIM, sulforaphane, calcium D-glucarate, methylated vitamins, or another supplement will improve symptoms or lower disease risk.

Taking a concentrated supplement based only on a genetic pathway can create new problems. It may be unnecessary, interact with medication, affect hormone-related symptoms, or distract from a more relevant cause.

Genetic Testing and Hormone Therapy

Menopausal hormone therapy should be personalized, but personalized care is not the same as gene-directed prescribing.

Established clinical decisions consider symptoms, age, time since menopause, uterine status, medical history, contraindications, route of administration, dose, preferences, and response to treatment. Systemic hormone therapy is the most effective treatment for hot flashes and night sweats, while local vaginal estrogen can be used for selected genitourinary symptoms.8

At present, a consumer functional-genomics report is not a validated replacement for those factors. A SNP result should not determine whether a woman is eligible for hormone therapy, which estrogen route she must use, whether testosterone will convert rapidly to estrogen, or the exact dose she needs.

Genetic information can matter when it identifies a recognized inherited condition that changes risk assessment. That is different from using a cluster of common wellness variants to prescribe hormones.

If treatment is not working as expected, the next step is a clinical reassessment. Review the diagnosis, dose, route, adherence, symptom target, side effects, sleep, thyroid status, medications, and other health conditions. Do not assume the explanation is a detox gene.

Can DNA Choose the Best Menopause Diet?

Nutrigenetics studies how genetic variation may affect responses to food and nutrients. It is an important research field, but commercial recommendations often move faster than clinical evidence.

A systematic review of nutrigenetic evidence frameworks found wide inconsistency in how scientific validity is evaluated. A credible gene-diet claim should be supported by appropriate study design, replication, meaningful effect size, statistical precision, generalizability, dose-response information, and control of bias and confounding.7

A report may suggest that you are less likely to tolerate a high-carbohydrate or high-saturated-fat diet. Treat that as a hypothesis, not a verdict.

Your real-world response still matters more. If a dietary pattern worsens LDL cholesterol, digestive symptoms, training performance, sleep, or quality of life, those measurable outcomes should guide the next conversation. A gene report does not need to explain the entire response before you adjust the plan.

Genetic testing also cannot diagnose broad “gluten intolerance” or “dairy intolerance” from a few wellness SNPs. Celiac disease, wheat allergy, lactose intolerance, and other digestive conditions have different causes and require different evaluation. Removing major food groups from a child’s or adult’s diet because of a lifestyle report can create unnecessary restriction.

Can Genetics Choose Your Ideal Exercise Type?

Exercise response has genetic components, but training history, current fitness, sleep, nutrition, health conditions, injuries, medications, age, access, and preference also matter.

A report that describes you as an endurance athlete or power athlete does not establish what you should or should not do. It cannot prove why you developed a migraine after a hill climb or why training for a triathlon felt unusually difficult.

Use genetics as one possible source of curiosity. Use actual performance, recovery, symptoms, heart rate, strength, and clinical evaluation as the primary feedback.

For women in menopause, a balanced plan usually needs more than one training quality. Strength, aerobic capacity, balance, mobility, and recovery each support different aspects of health. The right mix should evolve with your goals and condition rather than being dictated by a gene label.

Cardiovascular Genetics: Where Testing May Be More Actionable

Some of the most clinically meaningful genetic questions involve inherited cardiovascular conditions. Familial hypercholesterolemia, inherited cardiomyopathies, rhythm disorders, and other monogenic conditions can benefit from appropriate clinical testing and family assessment.

That does not mean every cardiovascular SNP report is ready for routine care. A 2025 American Heart Association scientific statement concluded that evidence remains insufficient to support direct-to-consumer genetic testing in routine cardiovascular care. It highlighted major variation across products, the false-negative risk of testing only selected variants, limited transparency in some commercial polygenic scores, and the need to confirm potentially actionable findings.6

Family history remains important. If a parent or sibling had premature heart disease, stroke, very high cholesterol, cardiomyopathy, sudden unexplained death, or a known pathogenic variant, ask whether a referral to a cardiovascular genetics clinic is appropriate.

Standard clinical information still matters. Blood pressure, lipids, glucose, smoking, physical activity, symptoms, medications, and family history can change care today. A genetic report should add context rather than replace these measures.

If a consumer test reports an important result related to BRCA, familial hypercholesterolemia, cardiomyopathy, or another recognized condition, do not act on the raw report alone. Confirm it in a clinical laboratory and review it with a genetics professional.1 3 6

APOE Results Require Context

APOE is commonly included in consumer reports because one variant is associated with increased susceptibility to late-onset Alzheimer disease. An APOE result is not a diagnosis, and it cannot predict whether or when a person will develop dementia.

Learning this information can cause significant distress, particularly when the person was not prepared for the result. Before ordering a test that includes APOE, understand whether you can opt out, how results are delivered, and whether professional counseling is available.

A lower-risk result should not lead a person to ignore brain health. A higher-risk result should not be treated as fate.

DNA Testing Cannot Replace Clinical Testing

A genetic report describes inherited information. It does not show what is happening in the body right now.

If a report suggests a thyroid pathway deserves attention, standard thyroid evaluation is still needed. If it suggests cardiovascular susceptibility, blood pressure and laboratory markers still matter. If it raises concern about blood sugar, measure glucose-related outcomes. If symptoms suggest celiac disease, pursue an appropriate diagnostic pathway rather than relying on a wellness score.

Genetics may help you ask a better question. Clinical history and validated testing help determine whether that question matters now.

This distinction protects women from treating a predicted tendency that is not currently causing a problem while missing an active condition that needs care.

Privacy Questions to Ask Before Sending Your DNA

Your DNA is permanent personal information. Before submitting a sample, read more than the test description.

Ask who owns the sample and data, whether the sample is stored, whether information may be used in research, whether data can be sold or shared, how deletion works, whether law enforcement access is possible, and what happens if the company is acquired or closes.

ACOG recommends that pretest counseling include confidentiality, sample handling, company ownership changes, and possible implications for life, disability, and long-term care insurance.3

The Genetic Information Nondiscrimination Act limits the use of genetic information by health insurers and many employers. It generally does not provide the same protection for life, disability, or long-term care insurance.2

Privacy policies can change. Save a copy of the policy and consent terms that apply when you test.

Should Children Receive Wellness Genetic Testing?

Testing a child for a clear medical indication can be valuable. Broad lifestyle testing for adult-onset risks, personality, diet, stress response, or optimal exercise raises different ethical concerns.

Children cannot fully consent to learning permanent information that may affect them later. The result may create labels, unnecessary restriction, anxiety, or family expectations without proven benefit.

A test should not be ordered simply because more information is available. For children, the strongest justification is usually that the result addresses a current clinical concern or creates a clear health benefit during childhood. Questions about predictive testing should be discussed with a pediatric genetics professional.

How to Evaluate a Genetic Test Before You Buy It

Use these questions to separate an informative test from an impressive marketing package.

What exact question will this test answer? “Optimize health” is too broad.
Is this clinical testing, consumer health testing, or a wellness report? The standards and appropriate uses differ.
Which variants are tested? A large number does not guarantee that the relevant variants are included.
Is the laboratory appropriately certified? Laboratory quality addresses analytical performance, not necessarily whether every interpretation is clinically useful.
Has the interpretation been independently validated? Ask for evidence supporting the exact report claim, not merely the gene’s role in a pathway.
Does the model apply to my ancestry? Risk estimates may not transfer equally across populations.4 6
Will a positive result require confirmation? High-impact findings usually should be confirmed before care changes.1 3
Is genetic counseling available? Interpretation should include personal and family history.
How will my sample and data be used? Review storage, research, commercial use, deletion, and company-sale policies.
What decision would change because of the result? If the answer is unclear, the test may add data without adding value.

What to Do With Results You Already Have

Do not panic over a red pathway or assume that green means protected. Consumer reports often use color and risk language to simplify complex probabilities.

Start by separating the findings into three groups.

Result Category	Recommended Response
Potentially high-impact medical finding	Confirm through an appropriate clinical laboratory and consult a genetics professional before changing care
Medication-response finding	Review the exact gene-drug relationship with the prescribing clinician and use validated guidance
Diet, supplement, exercise, mood, or detoxification suggestion	Treat as a hypothesis; compare it with symptoms, history, validated measurements, feasibility, and known evidence

Bring the complete report, not only a screenshot, to the appointment. Include the testing method, genes and variants assessed, result definitions, and company limitations.

If the report came from uploaded raw data, interpretation deserves additional caution. Third-party software can misread imputed or low-quality variants, and the underlying consumer test may never have been designed for the claimed medical use.1 6

Frequently Asked Questions About Genetic Testing for Menopause

Can a DNA Test Diagnose Perimenopause?

No. Perimenopause is assessed primarily from age, menstrual history, symptoms, and clinical context. A wellness genetic report cannot diagnose the menopause transition.

Can Genetic Testing Predict the Exact Age of Menopause?

Genetics contributes to reproductive aging, and researchers are studying polygenic predictors. A consumer test cannot reliably tell an individual the exact age at which natural menopause will occur.

Is a Polygenic Score Better Than a Single Gene Test?

It may capture more of the inherited contribution to a complex trait, but it is only useful if the score was rigorously developed, independently validated, calibrated for the population, and shown to improve decisions. More variants do not automatically mean more clinical value.4 6

Does an MTHFR Variant Mean I Need Methylated Vitamins?

No. Common MTHFR variants do not automatically establish a deficiency or determine a supplement form or dose. The CDC states that people with common variants can process folic acid and that intake matters more for blood folate than genotype.5

Can a COMT Result Explain My Anxiety or Brain Fog?

Not by itself. COMT is one part of complex neurobiology. Sleep, menopause symptoms, mental health, thyroid function, medication, stress, and other factors may be more clinically relevant.

Can Genetics Determine My Best Menopause Diet?

Not with the certainty often implied by marketing. A report can generate a hypothesis, but measurable health outcomes, food preferences, medical needs, and sustainability should guide the plan.1 7

Can Genetic Testing Choose My Hormone Therapy?

Routine consumer genomics is not an established method for selecting menopausal hormone therapy or an exact dose. Treatment should be based on symptoms, health history, risks, uterine status, preferences, and response.8

Should I Change Cancer Screening After a Consumer DNA Test?

Not without professional review. A positive result may require clinical confirmation. A negative limited panel does not eliminate hereditary risk, especially when personal or family history is concerning.1 2 3

The Bottom Line: Use DNA to Ask Better Questions

Genetic testing can be empowering when it answers a meaningful question and is interpreted within the full context of a woman’s health. It is most valuable when the evidence linking a variant to a condition is strong, the result can be confirmed, and there is a clear action that improves care.

It is less reliable when a commercial report turns common variants into precise claims about personality, detoxification, supplements, hormone doses, food intolerance, or ideal exercise.

The most responsible approach to genetic testing for menopause is neither blind enthusiasm nor blanket dismissal. It is informed curiosity.

At Menrva, we believe personalized care begins with listening to the woman, understanding her symptoms and history, and using technology where it adds real clinical value. Your DNA may contribute an important piece. It should never be mistaken for the whole picture.